Casi pharmaceuticals announces appointment of daniel lang, md as cfo and svp

Beijing , july 8, 2024 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products today announces appointment of daniel lang, md as chief financial officer and senior vice president, effective july 8 th, 2024. dr. lang has more than 30 years of experience as a physician scientist, investor, and biotech executive.
CASI Ratings Summary
CASI Quant Ranking